Louise Wang Zhiying Humphrey

Array ( [id] => 1391717 [patent_doc_number] => 06541226 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-04-01 [patent_title] => 'Method for specifically cleaving double-stranded DNA and kit for the method' [patent_app_type] => B1 [patent_app_number] => 09/549949 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 8340 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/541/06541226.pdf [firstpage_image] =>[orig_patent_app_number] => 09549949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1419867 [patent_doc_number] => 06518417 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-11 [patent_title] => 'Antisense nucleic acids targeting HBV' [patent_app_type] => B1 [patent_app_number] => 09/446289 [patent_app_country] => US [patent_app_date] => 2000-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6754 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/518/06518417.pdf [firstpage_image] =>[orig_patent_app_number] => 09446289 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 520780 [patent_doc_number] => 07186530 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-06 [patent_title] => 'Protein associated with cell stress response' [patent_app_type] => utility [patent_app_number] => 09/544776 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 9 [patent_no_of_words] => 14932 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/186/07186530.pdf [firstpage_image] =>[orig_patent_app_number] => 09544776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1475935 [patent_doc_number] => 06388170 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-14 [patent_title] => 'Bidirectional promoters and methods related thereto' [patent_app_type] => B1 [patent_app_number] => 09/545244 [patent_app_country] => US [patent_app_date] => 2000-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 6420 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/388/06388170.pdf [firstpage_image] =>[orig_patent_app_number] => 09545244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640031 [patent_doc_number] => 06395884 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Therapy for -galactosidase a deficiency' [patent_app_type] => B1 [patent_app_number] => 09/543921 [patent_app_country] => US [patent_app_date] => 2000-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 13 [patent_no_of_words] => 12662 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395884.pdf [firstpage_image] =>[orig_patent_app_number] => 09543921 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1377681 [patent_doc_number] => 06559129 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-05-06 [patent_title] => 'Cationic liposomal delivery system and therapeutic use thereof' [patent_app_type] => B1 [patent_app_number] => 09/538241 [patent_app_country] => US [patent_app_date] => 2000-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 14862 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/559/06559129.pdf [firstpage_image] =>[orig_patent_app_number] => 09538241 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407042 [patent_doc_number] => 06309839 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-30 [patent_title] => 'Screening methods for compounds that inhibit or stimulate helicase enzyme activity' [patent_app_type] => 1 [patent_app_number] => 9/539191 [patent_app_country] => US [patent_app_date] => 2000-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 10495 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/309/06309839.pdf [firstpage_image] =>[orig_patent_app_number] => 539191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1344667 [patent_doc_number] => 06586581 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-01 [patent_title] => 'Prolactin regulatory element binding protein and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/533494 [patent_app_country] => US [patent_app_date] => 2000-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 26536 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/586/06586581.pdf [firstpage_image] =>[orig_patent_app_number] => 09533494 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 131769 [patent_doc_number] => 07700569 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-04-20 [patent_title] => 'Use of stabilised oligonucleotides for preparing a medicine with antitumor activity' [patent_app_type] => utility [patent_app_number] => 09/937057 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6600 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/700/07700569.pdf [firstpage_image] =>[orig_patent_app_number] => 09937057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407927 [patent_doc_number] => 06228648 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Antisense modulation of ADAM10 expression' [patent_app_type] => 1 [patent_app_number] => 9/527154 [patent_app_country] => US [patent_app_date] => 2000-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22874 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228648.pdf [firstpage_image] =>[orig_patent_app_number] => 527154 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1493902 [patent_doc_number] => 06342356 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-01-29 [patent_title] => 'Methods and regents for identifying synthetic genetic elements' [patent_app_type] => B1 [patent_app_number] => 09/522728 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16798 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 136 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/342/06342356.pdf [firstpage_image] =>[orig_patent_app_number] => 09522728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1223548 [patent_doc_number] => 06699692 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-02 [patent_title] => 'Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin' [patent_app_type] => B2 [patent_app_number] => 09/515534 [patent_app_country] => US [patent_app_date] => 2000-02-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 66 [patent_figures_cnt] => 66 [patent_no_of_words] => 12734 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/699/06699692.pdf [firstpage_image] =>[orig_patent_app_number] => 09515534 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 123012 [patent_doc_number] => 07704962 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-04-27 [patent_title] => 'Small oligonucleotides with anti-tumor activity' [patent_app_type] => utility [patent_app_number] => 09/506979 [patent_app_country] => US [patent_app_date] => 2000-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 16646 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704962.pdf [firstpage_image] =>[orig_patent_app_number] => 09506979 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1046963 [patent_doc_number] => 06864359 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-03-08 [patent_title] => 'Structure-based screening techniques for drug discovery' [patent_app_type] => utility [patent_app_number] => 09/502984 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 30239 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/864/06864359.pdf [firstpage_image] =>[orig_patent_app_number] => 09502984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407518 [patent_doc_number] => 06300133 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'RNA transformation vectors derived from an uncapped single-component RNA virus' [patent_app_type] => 1 [patent_app_number] => 9/502710 [patent_app_country] => US [patent_app_date] => 2000-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 6 [patent_no_of_words] => 16808 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300133.pdf [firstpage_image] =>[orig_patent_app_number] => 502710 [rel_patent_id] =>[rel_patent_doc_number] =>)